Effects of metformin on atrial and ventricular arrhythmias: evidence from cell to patient
View Full Paper
Ask AI
Bookmark
Share
Why the study?
Metformin demonstrates broad cardiovascular benefits beyond glucose lowering, but its roles in cardiac arrhythmias remain unclear.
Design
Review
Authors
Discussion
Loading...
Member takes
Overview
Metformin-associated AF reduction in diabetes is hypothesis-generating; prospective RCTs needed before clinical consideration.
Structured PICO
P
Population
In vitro, in vivo, and clinical studies evaluating the effects of metformin on cardiac arrhythmias
I
Intervention
Metformin
This review highlights the potential of metformin to reduce atrial fibrillation incidence through AMPK-mediated structural and electrical remodeling, while noting a lack of clinical benefit for ventricular arrhythmias.
Limitations
- limited numbers of reports
Cite This Study
Nantsupawat et al. (2020) studied this question.
View Full Paper
Ask AI
Bookmark
Share